Siga Technologies (SIGA) Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Assets came in at $219.5 million in Q4 2025, down 10.18% on a YoY basis from $244.3 million in Q4 2024, and down 5.24% quarter-over-quarter from $231.6 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Assets for 16 consecutive years, with $219.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Assets fell 10.18% year-over-year to $219.5 million; the trailing twelve-month figure through Dec 2025 stood at $219.5 million (down 10.18% YoY), and the FY2025 full-year result was $219.5 million, down 10.18% from the prior year.
- Assets eased to $219.5 million in Q4 2025 per SIGA's latest filing, from $231.6 million in the prior quarter.
- Across five years, Assets topped out at $254.4 million in Q4 2023 and bottomed at $133.7 million in Q2 2021.
- Historically, Assets has averaged $195.9 million across 5 years, with a median of $195.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Assets surged 50.65% in 2022, then retreated 22.45% in 2023.
- Over 5 years, Assets stood at $214.7 million in 2021, then retreated by 9.17% to $195.0 million in 2022, then jumped by 30.41% to $254.4 million in 2023, then declined by 3.94% to $244.3 million in 2024, then retreated by 10.18% to $219.5 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $219.5 million, $231.6 million, and $235.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 150.01 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 4.32 Bn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 7.87 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 7.22 Bn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 219.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 219.47 Mn |
| Sep 30, 2025 | 231.60 Mn |
| Jun 30, 2025 | 235.33 Mn |
| Mar 31, 2025 | 247.07 Mn |
| Dec 31, 2024 | 244.34 Mn |
| Sep 30, 2024 | 195.35 Mn |
| Jun 30, 2024 | 192.66 Mn |
| Mar 31, 2024 | 243.15 Mn |
| Dec 31, 2023 | 254.35 Mn |
| Sep 30, 2023 | 158.38 Mn |
| Jun 30, 2023 | 146.51 Mn |
| Mar 31, 2023 | 183.92 Mn |
| Dec 31, 2022 | 195.04 Mn |
| Sep 30, 2022 | 204.22 Mn |
| Jun 30, 2022 | 159.94 Mn |
| Mar 31, 2022 | 184.55 Mn |
| Dec 31, 2021 | 214.73 Mn |
| Sep 30, 2021 | 135.56 Mn |
| Jun 30, 2021 | 133.69 Mn |
| Mar 31, 2021 | 138.77 Mn |